skip to content


Heparin sodium pork, HEPATHROMBIN ointment 30,000

Teofarma srl

Sale price £46.40 Regular price £70.00

Tax included. Shipping calculated at checkout.

HEPATHROMBIN ointment 30,000, Heparin sodium pork

Pack size:150g Dosage form:ointment

 

Heparin sodium pork, HEPATHROMBIN ointment 30,000, For acute swelling following blunt injuries.

 

Active Heparin sodium pork, HEPATHROMBIN ointment 30,000 ingredients

  • 300 IU pork heparin sodium

ingredients

  • Disodium edetate-2-water
  • Paraffins, microcrystalline
  • Allantoin
  • Tris[dodecylpoly(oxyethylene)-4]phosphate
  • Paraffin, thin liquid
  • Dexpanthenol
  • Glycerol monostearates
  • (Hexadecyl,octadecyl)-[(RS)-2-ethylhexanoate]-isopropyltetradecanoate (7:2:1)
  • Carbomer 980
  • Water, purified
  • Vaseline, white
  • Levomenthol
  • 2.2 mg sorbic acid
  • Trometamol

 

Heparin sodium pork, HEPATHROMBIN ointment 30,000 Indication :

 

  • The preparation is a medicine to reduce swelling.
  • It is used as a supportive treatment for:
    • Acute swelling following blunt injuries (bruises/bruises).
Dosage :
  • Always use the medicine exactly as described or exactly as agreed with your doctor or pharmacist. Please ask your doctor or pharmacist if you are unsure.
  • Unless otherwise prescribed by the doctor, the usual dose is:
    • The medicine should be applied thinly and evenly to the affected area 2 to 3 times a day.

 

  • Duration of application
    • The doctor decides on the duration of use. The medicine must not be used for longer than 10 days.
    • Please talk to your doctor or pharmacist if you have the impression that the effect is too strong or too weak.

 

  • If you have any further questions about using the medicine, contact your doctor or pharmacist.
Way :
  • The medicine should be applied thinly and evenly to the affected area 2 to 3 times a day.
  • After use, wash your hands thoroughly with soap.
Side effects :
  • Like all medicines, this medicine can cause side effects, although not everyone gets them.
  • The frequency information on side effects is based on the following categories:
    • Very common: may affect more than 1 in 10 people
    • Common: may affect up to 1 in 10 people
    • Uncommon: may affect up to 1 in 100 people
    • Rare: may affect up to 1 in 1,000 people
    • Very rare: may affect up to 1 in 10,000 people
    • Not known: Frequency cannot be estimated from the available data
  • possible side effects
    • Diseases of the blood and lymphatic system
      • Not known:
        • An occurrence of heparin-induced, antibody-mediated thrombocytopenia type II (HIT type II) (reduction in the number of blood platelets < 100,000/µl or a rapid drop in the number of platelets to < 50% of the initial value) with arterial and venous thrombosis or embolism, which can be fatal has not yet been reported when applied locally to the skin. However, since the absorption of heparin through healthy skin after local application has been described, this risk cannot be ruled out with certainty. Increased attention is therefore indicated (see the “Contraindication” and “Patient Information” categories).
        • It is known from the use of parenteral heparin [heparin solutions for injection under the skin or into a vein] that in patients without pre-existing hypersensitivity to heparin, the drop in the number of blood platelets usually occurs 6 - 14 days after the start of treatment. In patients with hypersensitivity to heparin, this decrease may occur within hours.
    • Immune system diseases
      • Very rare:
        • allergic reaction
    • Diseases of the skin and subcutaneous tissue
      • Very rare:
        • Allergic reactions such as redness of the skin and itching can occur, which usually disappear quickly after stopping the preparation.
    • For further information on allergies due to other ingredients, see the instructions for use!
  • Countermeasures
    • The medicine should be discontinued if allergic skin reactions occur. Please inform your doctor about this. Beyond that, no other special measures are necessary.
  • If you notice any side effects, contact your doctor or pharmacist. This also applies to side effects that are not specified.
Interactions :
  • Use together with other medicines
    • Tell your doctor or pharmacist if you are taking/using any other medicines, have recently taken/used any other medicines or might take/use any other medicines.
    • Interactions with other drugs are not known when used locally, but cannot be ruled out, especially with long-term use, as penetration of heparin through healthy skin has been described. An increased risk of bleeding cannot be ruled out, especially with drugs that interfere with blood clotting. Bruising may occur more frequently or increase in extent.
Contraindications :
  • The medicine must not be used
    • if you are allergic to heparin or any of the other ingredients of this medicine.
    • if you have an acute or a history of allergic fall in the number of blood platelets (thrombocytopenia type II) caused by heparin.
Pregnancy and breastfeeding :
  • If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
  • Previous experience with use in pregnant and breastfeeding women has shown no evidence of harmful effects.
  • Heparin does not cross the placenta and does not pass into breast milk.
Patient information :
  • Warnings and Precautions
    • Please talk to your doctor or pharmacist before using the medicine.
    • If new symptoms appear that may indicate a thrombosis or pulmonary embolism, such as
      • Swelling and feeling of warmth in the affected part of the body
      • reddened and tense skin, possibly blue discoloration
      • Feeling of tension and pain in the foot, calf and back of the knee (relief when elevated)
      • sudden shortness of breath, chest pain and weakness/collapse
    • The presence of heparin-induced thrombocytopenia type II must be ruled out and the blood platelet count (thrombocyte count) must be checked immediately.
    • If drugs that interfere with blood clotting are used at the same time, an increased risk of bleeding cannot be ruled out. Bruising may occur more frequently or increase in extent.
    • During treatment, injections into the muscle should be avoided due to the risk of bruising (hematomas).
    • The medicine should not be applied to mucous membranes, open wounds and/or weeping eczema.

 

  • Ability to drive and use machines
    • The medicine has no influence on the ability to drive or use machines.